Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial-Reference-Cited by-同舟云学术

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

Published:2019-12 Issue:10214 Volume:394 Page:2084-2095
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Clamp Andrew R,James Elizabeth C,McNeish Iain A,Dean Andrew,Kim Jae-Weon,O'Donnell Dearbhaile M,Hook Jane,Coyle Christopher,Blagden Sarah,Brenton James D,Naik Raj,Perren Tim,Sundar Sudha,Cook Adrian D,Gopalakrishnan Gosala S,Gabra Hani,Lord Rosemary,Dark Graham,Earl Helena M,Hall Marcia,Banerjee Susana,Glasspool Rosalind M,Jones Rachel,Williams Sarah,Swart Ann Marie,Stenning Sally,Parmar Mahesh,Kaplan Richard,Ledermann Jonathan A

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Ovarian cancer;Jayson;Lancet,2014

2. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference;Stuart;Int J Gynecol Cancer,2011

3. Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference;Bookman;Ann Oncol,2017

4. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial;Kehoe;Lancet,2015

5. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N Engl J Med,2010

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population;International Journal of Gynecologic Cancer;2024-09-03

2. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

3. Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial;Med;2024-08

4. SEOM–GEICO clinical guideline on epithelial ovarian cancer (2023);Clinical and Translational Oncology;2024-07-15

5. The SHOW RESPECT adaptable framework of considerations for planning how to share trial results with participants, based on qualitative findings from trial participants and site staff;Trials;2024-07-10